A comprehensive view of prescription drugs. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Health Care Sector Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

Pfizer first pharmaceutical company with over US$100.0B in sales, reporting sales of US$100.33B in 2022; profits increased 43% year-over-year to US$31.4B, more than triple the profits in 2020
Published: January 31, 2023 by CE Noticias Financieras (Latin America)
US Senator Elizabeth Warren asks FTC to look into Amgen’s US$28.0B bid to buy Horizon Therapeutics, Indivior’s US$145.0M offer to buy Opiant; Warren cites potential drug affordability and access issues, 'rampant consolidation’ in pharma industry
Published: January 30, 2023 by FiercePharma
Sales forecasts for Pfizer’s Paxlovid may change due to easing of Chinese zero-COVID policy, which could surge infection rate, increase Paxlovid demand; Pfizer has distributed millions of Paxlovid treatments in China since policy change
Published: January 30, 2023 by International Business Times
Health group Physicians Committee issues formal complaint that recent ’60 Minutes’ segment featuring Novo Norkisk’s obesity drug Wegovy breached fair balance rules for drug ads; Physicians Committee states segment ‘was effectively a drug ad’
Published: January 27, 2023 by Indian Pharma Industry: Policies
Thermo Fisher Scientific partners with AstraZeneca to develop solid tissue and blood-based CDx test; test to identify patients with non-small cell lung cancer who may be eligible for treatment with Tagrisso osimertinib
Published: January 25, 2023 by Clinical Lab Products

Ask us about our Health Care Sector market view

Trending Chart

Interactive chart with headline count